Can-Fite Files For Offering Of Up To 190.5M Shares
https://mayafiles.tase.co.il/rpdf/1425001-1426000/P1425882-00.pdf
The Daily Biotech Pulse: Adagio’s Antibody Effective Against Omicron, Sarepta Terminates Gene Therapy Deal, AstraZeneca Inks Oncology Pact
Here's a roundup of top developments in the biotech space over the last 24 hours:
45 Biggest Movers From Yesterday
Gainers
Puxin Limited (NYSE: NEW) shares surged 80% to close at $0.54 on Wednesday after reporting results for the second quarter.
26 Stocks Moving In Wednesday’s Mid-Day Session
Gainers
Puxin Limited (NYSE: NEW) jumped 100.5% to $0.6016 after reporting results for the second quarter.
55 Biggest Movers From Yesterday
Gainers
Reliance Global Group, Inc. (NASDAQ: RELI) shares jumped 78.7% to close at $5.45 on Tuesday after gaining around 6% on Monday.
65 Biggest Movers From Yesterday
Gainers
Society Pass Incorporated (NASDAQ: SOPA) shares climbed 240.2% to close at $11.26 on Monday after the company reported addition to the Russell 2000 Index.
Mid-Afternoon Market Update: Dow Tumbles 500 Points; Bluerock Residential Growth Shares Spike Higher
Toward the end of trading Monday, the Dow traded down 1.42% to 34,862.49 while the NASDAQ fell 1.38% to 14,960.51. The S&P also fell, dropping 1.34% to 4,558.87.
Can-Fite Shares Rally As Namodenoson Clears All Cancer Lesions In Liver Cancer Patient
Can-Fite BioPharma Ltd (NYSE: CANF) announced that the last liver cancer patient treated under an Open-Label Extension program of its concluded Phase 2 study of Namodenoson